Celgene (CELG) Debt to Equity Ratio

Current and historical debt to equity ratio values for Celgene (CELG) over the last 10 years.

Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $112.486B $11.229B
Celgene Corp. is an independent biopharmaceutical company engaged primarily in the discovery, development and commercialization of orally administered, small molecule drugs for the treatment of cancer and immunological diseases.